These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2997837)

  • 1. Fatty infiltration of the liver: evaluation by proton spectroscopic imaging.
    Heiken JP; Lee JK; Dixon WT
    Radiology; 1985 Dec; 157(3):707-10. PubMed ID: 2997837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton spectroscopic imaging (Dixon method) of the liver: clinical utility.
    Schertz LD; Lee JK; Heiken JP; Molina PL; Totty WG
    Radiology; 1989 Nov; 173(2):401-5. PubMed ID: 2552499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty infiltration of the liver: demonstration by proton spectroscopic imaging. Preliminary observations.
    Lee JK; Dixon WT; Ling D; Levitt RG; Murphy WA
    Radiology; 1984 Oct; 153(1):195-201. PubMed ID: 6089264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatic metastases by proton spectroscopic imaging. Work in progress.
    Lee JK; Heiken JP; Dixon WT
    Radiology; 1985 Aug; 156(2):429-33. PubMed ID: 2989973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience in noninvasively quantifying hydrogen magnetic resonance imaging spectroscopic hepatic fat concentrations in patients with fatty hepatosis before and after treatment with Eslidin].
    Shariia MA; Shriaev GA; Titov VN; Ivanova KV
    Vestn Rentgenol Radiol; 2013; (2):50-4. PubMed ID: 23879042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of hepatic lipid: high-speed T2-corrected multiecho acquisition at 1H MR spectroscopy--a rapid and accurate technique.
    Pineda N; Sharma P; Xu Q; Hu X; Vos M; Martin DR
    Radiology; 2009 Aug; 252(2):568-76. PubMed ID: 19546430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton chemical shift imaging: an evaluation of its clinical potential using an in vivo fatty liver model.
    Rosen BR; Carter EA; Pykett IL; Buchbinder BR; Brady TJ
    Radiology; 1985 Feb; 154(2):469-72. PubMed ID: 3966134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.
    Guiu B; Petit JM; Loffroy R; Ben Salem D; Aho S; Masson D; Hillon P; Krause D; Cercueil JP
    Radiology; 2009 Jan; 250(1):95-102. PubMed ID: 19092092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiquantitative analysis of fatty liver using spectroscopic imaging by dephasing amplitude changing (SIDAC).
    Ohtomo K; Yamada S; Aoyama H; Miyazaki T; Iriguchi N; Minami M; Yoshikawa K; Itai Y; Iio M; Ogata I
    Radiat Med; 1987; 5(4):104-6. PubMed ID: 3423297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver. Chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans.
    Mitchell DG; Kim I; Chang TS; Vinitski S; Consigny PM; Saponaro SA; Ehrlich SM; Rifkin MD; Rubin R
    Invest Radiol; 1991 Dec; 26(12):1041-52. PubMed ID: 1765436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model.
    van Werven JR; Marsman HA; Nederveen AJ; ten Kate FJ; van Gulik TM; Stoker J
    Magn Reson Imaging; 2012 Jan; 30(1):112-21. PubMed ID: 21940131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual gradient-echo in-phase and opposed-phase hepatic MR imaging: a useful tool for evaluating more than fatty infiltration or fatty sparing.
    Merkle EM; Nelson RC
    Radiographics; 2006; 26(5):1409-18. PubMed ID: 16973772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.
    Krssák M; Hofer H; Wrba F; Meyerspeer M; Brehm A; Lohninger A; Steindl-Munda P; Moser E; Ferenci P; Roden M
    Eur J Radiol; 2010 Jun; 74(3):e60-6. PubMed ID: 19406596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H NMR spectroscopic studies of lipid extracts from human fatty liver.
    Pollesello P; Masutti F; Crocè LS; Toffanin R; Eriksson O; Paoletti S; Höckerstedt K; Tiribelli C
    Biochem Biophys Res Commun; 1993 May; 192(3):1217-22. PubMed ID: 8507193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques.
    Schwenzer NF; Machann J; Martirosian P; Stefan N; Schraml C; Fritsche A; Claussen CD; Schick F
    Invest Radiol; 2008 May; 43(5):330-7. PubMed ID: 18424954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic unsaturated fatty acids in patients with non-alcoholic fatty liver disease assessed by 3.0T MR spectroscopy.
    van Werven JR; Schreuder TC; Nederveen AJ; Lavini C; Jansen PL; Stoker J
    Eur J Radiol; 2010 Aug; 75(2):e102-7. PubMed ID: 20116951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of hepatic lipid composition: Advancing understanding and management of fatty liver disorders.
    Johnson NA; Walton DW; Sachinwalla T; Thompson CH; Smith K; Ruell PA; Stannard SR; George J
    Hepatology; 2008 May; 47(5):1513-23. PubMed ID: 18393289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fatty liver quantification with line scan echo planar spectroscopic imaging (LSEPSI)].
    Shinmoto H; Oshio K; Yuasa Y; Tanimoto A; Momoshima S; Kuribayashi S; Saito H; Imai Y; Mulkern RV
    Nihon Igaku Hoshasen Gakkai Zasshi; 2001 Nov; 61(13):715-20. PubMed ID: 11766396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling.
    Sevastianova K; Hakkarainen A; Kotronen A; Cornér A; Arkkila P; Arola J; Westerbacka J; Bergholm R; Lundbom J; Lundbom N; Yki-Järvinen H
    Radiology; 2010 Aug; 256(2):466-73. PubMed ID: 20656836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.